PMEF
WST icon

Point72 Middle East FZE’s West Pharmaceutical WST Stock Holding History

Point72 Middle East FZE’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-300
Closed -$106K – 1329
2023
Q4 		$106K Buy
+300
New +$106K ﹤0.01% 1181

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Point72 Middle East FZE's WST Position: Q1 2024 in Review

Point72 Middle East FZE sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 12,694 shares — an estimated $4.47M sold.

Point72 Middle East FZE first reported a position in WST in Q4 2022 and held it in 4 quarters. The position peaked at $4.47M in Q4 2023. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Point72 Middle East FZE reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 12,694 West Pharmaceutical shares in Q1 2024, an estimated $4.47M.
  • Point72 Middle East FZE first reported a position in West Pharmaceutical in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's West Pharmaceutical position peaked at $4.47M in Q4 2023.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.